Timothy Connors - Genzyme Corp | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 118 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations

Anouk Lindley,Gerald Prager,Michael Bitzer,Timothy C. Burn,Christine F. Lihou, Elisabeth Croft

CANCER RESEARCH AND TREATMENTno. 3 (2024): 847-855

引用0浏览0WOS引用

Zebrafish Drug Screening Identifies Erlotinib As an Inhibitor of Wnt/β-Catenin Signaling and Self-Renewal in T-cell Acute Lymphoblastic Leukemia

Majd A. Al-Hamaly,Anna H. Cox,Meghan G. Haney,Wen Zhang, Emma C. Arvin,Shilpa Sampathi, Mary Wimsett,Chunming Liu,Jessica S. Blackburn

BIOMEDICINE & PHARMACOTHERAPY (2024)

引用0浏览0WOS引用

Abstract 1126: Extracellular Vesicle Mediated Radioresistance in H3K27M-diffuse Midline Glioma

Viral Oza,Shilpa Sampathi, Yelena Chernyavskava,Karina Martínez‐Flores,Jessica S. Blackburn

Cancer researchno. 6_Supplement (2024): 1126-1126

引用0浏览0引用

Supplementary Data from Clinicogenomic Analysis of ≪i>fgfr2</i>-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib

Ian M. Silverman,Antoine Hollebecque,Luc Friboulet,Sherry Owens, Robert C. Newton,Huiling Zhen,Luis Féliz,Camilla Zecchetto,Davide Melisi,Timothy Burn

openalex（2023）

引用0浏览0引用

Supplementary Data from Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity

Phillip C.C. Liu,Eian Caulder, Jun Li,Paul Waeltz,Alex Margulis,Richard Wynn,Mary Becker-Pasha,Yanlong Li,Erin Crowgey,Gregory Hollis,Patrick Haley,Richard B. Sparks,Andrew P. Combs, James D. Rodgers,Timothy C. Burn,Kris Vaddi,Jordan S. Fridman

crossref（2023）

引用0浏览0引用

Supplementary Data from Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity

Phillip C.C. Liu,Eian Caulder,Jun Li,Paul Waeltz,Alex Margulis,Richard Wynn,Mary Becker-Pasha,Yanlong Li,Erin Crowgey,Gregory Hollis,Patrick Haley,Richard B. Sparks,Andrew P. Combs, James D. Rodgers,Timothy C. Burn,Kris Vaddi,Jordan S. Fridman

openalex（2023）

引用0浏览0引用

Abstract 3488: Truncated FGFR2 - a Clinically Actionable Oncogene in Multiple Cancers

Daniel Kaspar Zingg,Jinhyuk Bhin,Julia Yemelyanenko,Sjors M. Kas,Catrin Lutz,Chi-Chuan Lin,Sjoerd Klarenbeek,Jessica K. Lee,Ian M. Silverman,Stefano Annunziato,Marieke van de Ven,Siraj M. Ali,Timothy C. Burn,Shridar Ganesan,Lodewyk F. Wessels,Jos Jonkers

Cancer Researchno. 7_Supplement (2023): 3488-3488

引用0浏览0引用

Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations

K Murugesan,A Necchi,T C Burn,O Gjoerup, R Greenstein,M Krook,J A López,M Montesion, H Nimeiri,A R Parikh,S Roychowdhury, S Schwemmers,I M Silverman,A Vogel

ESMO open（2022）

引用3浏览0WOS引用

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers (vol 608, pg 609, 2022)

NATURE（2022）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn